125 related articles for article (PubMed ID: 15010475)
1. Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Laburthe M
J Biol Chem; 2004 May; 279(20):20927-34. PubMed ID: 15010475
[TBL] [Abstract][Full Text] [Related]
2. Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.
Moody TW; Berna MJ; Mantey S; Sancho V; Ridnour L; Wink DA; Chan D; Giaccone G; Jensen RT
Eur J Pharmacol; 2010 Jul; 637(1-3):38-45. PubMed ID: 20388507
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor 2 drives migration in a colon cancer cell line but not in noncancerous human epithelial cells.
Périco LL; Vegso AJ; Baggio CH; MacNaughton WK
Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G525-G542. PubMed ID: 38440826
[TBL] [Abstract][Full Text] [Related]
4. The PAR2 signal peptide prevents premature receptor cleavage and activation.
Liu B; Lee G; Wu J; Deming J; Kuei C; Harrington A; Wang L; Towne J; Lovenberg T; Liu C; Sun S
PLoS One; 2020; 15(2):e0222685. PubMed ID: 32078628
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation.
Ma Y; Bao-Han W; Lv X; Su Y; Zhao X; Yin Y; Zhang X; Zhou Z; MacNaughton WK; Wang H
PLoS One; 2013; 8(8):e72383. PubMed ID: 23991105
[TBL] [Abstract][Full Text] [Related]
6. PAR2-dependent phosphorylation of TRPV4 at the trigeminal nerve terminals contributes to tongue cancer pain.
Akasaka R; Furukawa A; Hayashi Y; Hitomi S; Koyama R; Oshima E; Tamura M; Yonemoto M; Hojo Y; Takahashi R; Shibuta I; Iwata K; Yonehara Y; Shinoda M
J Oral Biosci; 2023 Dec; 65(4):356-364. PubMed ID: 37838226
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome.
Jimenez-Vargas NN; Pattison LA; Zhao P; Lieu T; Latorre R; Jensen DD; Castro J; Aurelio L; Le GT; Flynn B; Herenbrink CK; Yeatman HR; Edgington-Mitchell L; Porter CJH; Halls ML; Canals M; Veldhuis NA; Poole DP; McLean P; Hicks GA; Scheff N; Chen E; Bhattacharya A; Schmidt BL; Brierley SM; Vanner SJ; Bunnett NW
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7438-E7447. PubMed ID: 30012612
[TBL] [Abstract][Full Text] [Related]
8. Protease-Activated Receptor 2 Controls Vascular Smooth Muscle Cell Proliferation in Cyclic AMP-Dependent Protein Kinase/Mitogen-Activated Protein Kinase Kinase 1/2-Dependent Manner.
Williams MD; Bullock MT; Johnson SC; Holland NA; Vuncannon DM; Oswald JZ; Adderley SP; Tulis DA
J Vasc Res; 2023; 60(4):213-226. PubMed ID: 37778342
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells.
Shah H; Hill TA; Lim J; Fairlie DP
J Cell Commun Signal; 2023 Dec; 17(4):1293-1307. PubMed ID: 37991681
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Trypsin Accelerates Wound Healing
Xiang Y; Jiang Y; Lu L
ACS Pharmacol Transl Sci; 2024 Jan; 7(1):274-284. PubMed ID: 38230283
[TBL] [Abstract][Full Text] [Related]
11. Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer.
Witte D; Zeeh F; Gädeken T; Gieseler F; Rauch BH; Settmacher U; Kaufmann R; Lehnert H; Ungefroren H
J Clin Med; 2016 Nov; 5(12):. PubMed ID: 27916875
[TBL] [Abstract][Full Text] [Related]
12. Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases.
Carroll EL; Bailo M; Reihill JA; Crilly A; Lockhart JC; Litherland GJ; Lundy FT; McGarvey LP; Hollywood MA; Martin SL
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072295
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Protease-activated receptor 2 antagonists derived from phenylalanine for the treatment of breast cancer.
Kim T; Lee Y; Lim H; Kim Y; Cho H; Namkung W; Han G
Bioorg Chem; 2024 May; 150():107496. PubMed ID: 38850590
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor 2: a promising therapeutic target for women's cancers.
Shah H; Fairlie DP; Lim J
J Pharmacol Exp Ther; 2024 May; ():. PubMed ID: 38719478
[TBL] [Abstract][Full Text] [Related]
15. 1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2.
Chinellato M; Gasparotto M; Quarta S; Ruvoletto M; Biasiolo A; Filippini F; Spiezia L; Cendron L; Pontisso P
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895957
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between TGF-β and EGF receptors via direct phosphorylation.
Moustakas A
J Cell Biol; 2024 Apr; 223(4):. PubMed ID: 38506732
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor signaling and colon cancer progression.
Xie G; Raufman JP
J Cancer Metastasis Treat; 2016 Jun; 2():195-200. PubMed ID: 32671227
[TBL] [Abstract][Full Text] [Related]
18. Retraction: The PAR2 signal peptide prevents premature receptor cleavage and activation.
Liu B; Lee G; Wu J; Deming J; Kuei C; Harrington A; Wang L; Towne J; Lovenberg T; Liu C; Sun S
PLoS One; 2024; 19(6):e0305363. PubMed ID: 38843168
[No Abstract] [Full Text] [Related]
19. Epidermal growth factor receptor transactivation is required for proteinase-activated receptor-2-induced COX-2 expression in intestinal epithelial cells.
Hirota CL; Moreau F; Iablokov V; Dicay M; Renaux B; Hollenberg MD; MacNaughton WK
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G111-9. PubMed ID: 22517768
[TBL] [Abstract][Full Text] [Related]
20. Structure, function and pathophysiology of protease activated receptors.
Adams MN; Ramachandran R; Yau MK; Suen JY; Fairlie DP; Hollenberg MD; Hooper JD
Pharmacol Ther; 2011 Jun; 130(3):248-82. PubMed ID: 21277892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
